Robert L. Nussbaum - Mar 12, 2022 Form 4 Insider Report for Invitae Corp (NVTA)

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Stock symbol
NVTA
Transactions as of
Mar 12, 2022
Transactions value $
-$130,993
Form type
4
Date filed
3/16/2022, 08:52 PM
Previous filing
Nov 15, 2021
Next filing
Apr 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Award $0 +14.7K +5.98% $0.00 261K Mar 12, 2022 Direct F1, F2
transaction NVTA Common Stock Sale -$131K -19.6K -7.51% $6.69* 241K Mar 14, 2022 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued upon settlement of a restricted stock unit award that vests in two equal installments, with 1/2 of the remaining award vesting on March 12, 2023, subject to continued service with the issuer through such vesting date.
F2 Includes an aggregate of 91,486 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
F3 Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
F4 Represents a weighted average sale price. Actual sale prices ranged from $6.6873 to $6.6876 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.